Use of high-throughput methods for early stage formulation evaluation and their correlation to stability studies
AbbVie preformulation is an early discovery biologics group working to optimise antibodies prior to downstream assays and clinical delivery.
Join Brittney Mills, PhD, as she explains how AbbVie uses the Prometheus to evaluate conformational and colloidal stability of their candidates. She will discuss the goals of their early formulations group; how Prometheus nanoDSF compares to DSC and its advantages in material usage; the predictive merits of data derived from Prometheus; and how accelerated stability studies validate the initial screening parameters.
How to find promising small molecule lead compounds with biophysical tools
Watch this webinar if you’re working in the field of small molecule drug discovery and want to learn how sc...
How to study molecular interactions of membrane proteins without compromising their native structure
The desire to use technology that allows you to study membrane proteins in close-to-native conditions is sp...
Sign up to receive the latest NanoTemper news, product updates, event announcements and more